Inceptionr LLC decreased its holdings in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) by 61.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,005 shares of the real estate investment trust's stock after selling 4,792 shares during the quarter. Inceptionr LLC's holdings in National Health Investors were worth $208,000 at the end of the most recent quarter.
Several other institutional investors also recently modified their holdings of the stock. Quarry LP purchased a new position in National Health Investors in the 3rd quarter worth approximately $27,000. Covestor Ltd increased its position in shares of National Health Investors by 2,700.0% during the 3rd quarter. Covestor Ltd now owns 420 shares of the real estate investment trust's stock valued at $35,000 after purchasing an additional 405 shares during the last quarter. Point72 DIFC Ltd purchased a new position in shares of National Health Investors during the 3rd quarter valued at about $35,000. Loomis Sayles & Co. L P purchased a new position in shares of National Health Investors during the 3rd quarter valued at about $38,000. Finally, Assetmark Inc. lifted its position in National Health Investors by 27.8% in the 3rd quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust's stock worth $54,000 after buying an additional 141 shares during the last quarter. 62.51% of the stock is currently owned by institutional investors.
National Health Investors Trading Up 2.3 %
Shares of NYSE NHI traded up $1.71 during midday trading on Friday, reaching $75.08. The company had a trading volume of 146,722 shares, compared to its average volume of 201,370. The stock has a market cap of $3.43 billion, a PE ratio of 25.80, a price-to-earnings-growth ratio of 4.42 and a beta of 1.08. National Health Investors, Inc. has a one year low of $57.80 and a one year high of $86.13. The firm's fifty day moving average price is $69.35 and its 200-day moving average price is $74.86. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92.
National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.03. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The firm had revenue of $85.75 million during the quarter, compared to the consensus estimate of $81.13 million. On average, equities research analysts anticipate that National Health Investors, Inc. will post 4.41 earnings per share for the current year.
National Health Investors Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 2nd. Shareholders of record on Monday, March 31st will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.79%. The ex-dividend date is Monday, March 31st. National Health Investors's payout ratio is 115.38%.
Analysts Set New Price Targets
Separately, Truist Financial decreased their price target on shares of National Health Investors from $78.00 to $72.00 and set a "hold" rating on the stock in a research note on Monday, December 23rd. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $79.00.
Get Our Latest Analysis on NHI
National Health Investors Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.